Release Date: 27/02/13 15:39 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 1.37MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%